Mon, Oct 20, 2014, 11:06 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Apricus Biosciences, Inc. Message Board

  • mecosmo2 mecosmo2 Jan 15, 2014 3:36 PM Flag

    Apricus press releases fot 2013 for your DD dont listen to the Trash on the Board!

    Apricus Announces National Phase Approval for Erectile Dysfunction Cream - Vitaros(R) in France
    December 16, 2013 Apricus Expands Exclusive License Agreement With Its Partner in Germany to Market Vitaros(R) in Additional European Countries
    December 11, 2013 Apricus Elects Kleanthis G. Xanthopoulos, Ph.D. as New Chairman
    November 25, 2013 Apricus Biosciences Announces National Phase Approval for Erectile Dysfunction Cream - Vitaros(R) in Italy
    November 13, 2013 Apricus Biosciences Provides Third Quarter 2013 Corporate Update
    November 13, 2013 Apricus and Laboratoires Majorelle Sign Exclusive License Agreement to Market Topical Erectile Dysfunction Cream Vitaros(R) in France, Monaco and Certain African Countries
    November 12, 2013 Apricus Biosciences to Host Third Quarter 2013 Earnings Webcast Live on Wednesday, November 13, 2013
    November 05, 2013 Apricus Biosciences Announces Third Quarter 2013 Corporate Update Conference Call
    October 07, 2013 Apricus Biosciences Announces National Phase Approval for Erectile Dysfunction Cream - Vitaros(R) in Germany
    September 09, 2013 Apricus Biosciences Updates Presentation Time at the 2013 Stifel Nicolaus Healthcare Conference
    September 04, 2013 Apricus Biosciences to Present at the 2013 Stifel Nicolaus Healthcare Conference
    August 29, 2013 Apricus Biosciences Provides Vitaros(R) Swissmedic Update
    August 15, 2013 Apricus Biosciences Receives National Phase Approvals for Vitaros(R) in Ireland and the Netherlands
    August 12, 2013 Apricus Biosciences Reports Corporate Update
    August 09, 2013 Apricus Biosciences Announces Corporate Update Conference Call
    June 21, 2013 Apricus Biosciences Presents Vitaros(R) Poster at the International Symposium on Prostate, Androgens and Men's Sexual Health
    June 10, 2013 Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction
    May 23, 2013 Apricus Biosciences Prices $17.1 Million Public Offering of Common Stock and Warrants
    May 22, 2013 Apricus Biosciences Announces Proposed Public Offering of Common Stock and Warrants
    May 10, 2013 Apricus Biosciences Provides First Quarter 2013 Corporate Update
    May 07, 2013 Apricus Biosciences Announces First Quarter 2013 Financial Results Conference Call
    May 07, 2013 Apricus Biosciences Announces Poster Presentation of Vitaros(R) Data in Men Previously Unresponsive to PDE-5 Inhibitors at American Urological Association Annual Meeting
    April 25, 2013 Apricus Biosciences Receives Notice of Allowance for First Prevonco(tm) Patent in the United States
    April 18, 2013 Apricus Biosciences to Present at 2013 BIO International Convention
    April 01, 2013 Apricus Biosciences Announces Sale of Non-Core Assets
    March 18, 2013 Apricus Biosciences Provides Corporate Update; Files Annual Report for Quarter and Year Ended December 31, 2012
    March 18, 2013 Apricus Biosciences Appoints Richard W. Pascoe as Chief Executive Officer
    March 14, 2013 Apricus Biosciences Announces 2012 Year End Financial Results Conference Call
    March 14, 2013 Apricus Biosciences Announces Ceasing of Financing of French Subsidiaries
    March 13, 2013 Apricus Biosciences to Present at the 25th Annual ROTH Conference
    March 07, 2013 Apricus Biosciences to Present at BIO-Europe Spring 2013
    February 06, 2013 Apricus Biosciences to Present at the 15th Annual BIO CEO & Investor Conference
    January 03, 2013 Apricus Biosciences Announces Corporate Goals for 2013

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies